Skip to main content
Fig. 3 | Hereditas

Fig. 3

From: Elevated HMGB1 promotes the malignant progression and contributes to cisplatin resistance of non-small cell lung cancer

Fig. 3

HMGB1 promoted the malignant transformation of A549 cells and A549-DDP cells. (a-b) IC50 values of cisplatin and paclitaxel treatment on A549 cells and A549-DDP cells. (c) Clony formation assay was used to determine the cells’ proliferative ability. (d) Flow cytometry was performed to measure the apoptosis rates of cells. * P < 0.05, ** P < 0.01 and *** P < 0.001

Back to article page

Hereditas

ISSN: 1601-5223

Contact us